Indications and uses
temporarily relieves minor aches and pains due to: backache muscular aches the common cold toothache headache menstrual cramps minor pain of arthritis temporarily reduces fever
temporarily relieves minor aches and pains due to: backache muscular aches the common cold toothache headache menstrual cramps minor pain of arthritis temporarily reduces fever
do not take more than directed the smallest effective dose should be used drink a full glass of water with each dose adults and children 12 years and older take 1 tablet every 8 to 12 hours while symptoms last for the first dose you may take 2 tablets within the first hour do not exceed 2 tablets in any 8- to 12-hour period do not exceed 3 tablets in a 24-hour period children under 12 years: ask a doctor
each tablet contains: sodium 20 mg store at 20°-25°C (68°-77°F). Avoid high humidity and excessive heat above 40°C (104°F) see end flap for expiration date and lot number
Naproxen sodium 220 mg (naproxen 200 mg) (NSAID)*
*nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
ask a health professional before use. It is especially important not to use naproxen sodium during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
In case of overdose, get medical help or contact a Poison Control Center right away.
croscarmellose sodium, FD&C blue #2 aluminum lake, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, silicon dioxide, talc, titanium dioxide
Call 1-800-426-9391 8:30 AM-4:00 PM ET, Monday-Friday
FAMILY
wellness™
COMPARE TO THE ACTIVE INGREDIENT OF
ALEVE® BACK & MUSCLE PAIN TABLETS†
NDC 55319-714-08
ALL DAY
PAIN RELIEF
BACK & MUSCLE PAIN
NAPROXEN SODIUM TABLETS, 220 mg
Pain Reliever/Fever Reducer (NSAID)
Strength To Last 12 Hours
24 TABLETS
Actual Size
100% SATISFACTION
GUARANTEED
OR YOUR MONEY BACK
TAMPER EVIDENT: DO NOT USE IF IMPRINTED
SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
DISTRIBUTED BY:
MIDWOOD BRANDS, LLC
500 VOLVO PARKWAY,
CHESAPEAKE , VA 23320
NOT 100% SATISFIED?
Return package and unused
product within 30 days to any
Family Dollar store for a refund
(with receipt) or exchange.
†This product is not manufactured or
distributed by Bayer HealthCare LLC,
owner of the registered trademark
Aleve® Back & Muscle Pain Tablets.
50844 ORG041841708

Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 55319-714 | 55319-714-08 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204872-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A204872-001 | NAPROXEN SODIUM | EQ 200MG BASE | TABLET / ORAL | 2017-01-23 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A204872-001 | NAPROXEN SODIUM | EQ 200MG BASE | TABLET / ORAL | 2017-01-23 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A204872-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 2017-01-23 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8c4499c0-4c91-4729-a2d0-ab348e3c14c2 | 6df0523a-10ee-4fdf-9dad-cf9993ff07d5 | 2023-05-22 | Warnings | 6df0523a-10ee-4fdf-9dad-cf9993ff07d5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.